Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today reported financial results and recent ...

Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the ...

A poster was presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL in June titled “Phase 2 trial of Ozuriftamab Vedotin (BA3021), a Conditionally Binding ...

A growing number of social media users are calling out a Wildwood pizza place over stickers at the business that include Nazi ...

C4T had a productive Type C meeting with the U.S. Food and Drug Administration (FDA) that enabled further refinement of the cemsidomide registrational development plan. By year-end 2025, C4T expects ...

Washington, D.C., a city at the heart of American governance, finds itself at the epicenter of a renewed debate over its ...

Hostels at Rivers State University (RSU) have become sources of fear and distress, with a series of unsettling incidents ...

We found no evidence that Home Depot signed a $250 million deal with DHS allowing immigration arrests on its properties. We rate this claim False. Email interview with Beth Marlowe, a Home Depot ...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...

Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year. IBSRELA generated net sales re ...

ANZMES is a founding member of the World ME Alliance, and a member of the Neurological Alliance NZ, NZ Carers Alliance, long ...